Immunogenicity and Efficacy of High-dose Trivalent Inactivated Seasonal Influenza Vaccine(Fluzone High Dose) in Immunocompromised Children and Young Adults.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 09 Jan 2017
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics; Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 04 Jan 2017 Planned End Date changed from 1 Dec 2016 to 1 Jun 2017.
- 13 Jan 2016 Planned End Date changed from 1 Dec 2015 to 1 Dec 2016, according to ClinicalTrials.gov record.